• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Sunday 07/22/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

CTRX

  • 4:42 PM

    CRANFORD, N.J., Aug. 23, 2016 /PRNewswire/ — Citius Pharmaceuticals, Inc. (“Citius”) (OTC BB: CTXR), a specialty pharmaceutical company dedicated to developing and commercializing adjunctive cancer care and critical care drug products, announced completion of market research with in-depth interviews on patient-reported signs and symptoms of hemorrhoids and treatment outcomes with its Hydro-Lido product. Citius and the market research group conducted in-depth, in-person and telephonic interviews of patients who were diagnosed with grade II and grade III hemorrhoid disease. The interviews

    Read more
  • 2:56 PM

    HALIFAX, Nova Scotia, Sep 05, 2014 (BUSINESS WIRE) — Emera Inc. (TSX:EMAx) today announced it has entered into a subscription agreement with Algonquin Power & Utilities Corp (TSX:AQN) (“Algonquin”) under which Emera has subscribed for 7,865,170 subscription receipts (“Odell Subscription Receipts”) at a price of $8.90 per subscription receipt, for an aggregate subscription price of $70 million. Each subscription receipt represents a right to one common share of Algonquin. The investment is made under the Strategic Investment Agreement Emera has

    Read more
  • 2:56 PM

    HALIFAX, Nova Scotia, Sep 05, 2014 (BUSINESS WIRE) — Emera Inc. (TSX:EMAx) today announced it has entered into a subscription agreement with Algonquin Power & Utilities Corp (TSX:AQN) (“Algonquin”) under which Emera has subscribed for 7,865,170 subscription receipts (“Odell Subscription Receipts”) at a price of $8.90 per subscription receipt, for an aggregate subscription price of $70 million. Each subscription receipt represents a right to one common share of Algonquin. The investment is made under the Strategic Investment Agreement Emera has

    Read more
Public Wire Banner